These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8785172)

  • 1. A combination therapy of psychotropic drugs and antihistaminics or antiallergics in patients with chronic urticaria.
    Hashiro M; Yamatodani Y
    J Dermatol Sci; 1996 Mar; 11(3):209-13. PubMed ID: 8785172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosomatic treatment of a case of chronic urticaria.
    Hashiro M
    J Dermatol; 1995 Sep; 22(9):686-9. PubMed ID: 8537557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and safety of astemizole in the treatment of allergic rhinitis and urticaria: a systematic review with meta-analysis].
    Gutiérrez Castrellón P; Ramírez Mayans J; López Pérez G
    Rev Alerg Mex; 2005; 52(3):113-26. PubMed ID: 16158785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of leukotriene receptor antagonist with anti-H1 receptor antagonist plus anti-H2 receptor antagonist for treatment of refractory chronic idiopathic urticaria.
    Wan KS; Chang YS
    J Dermatolog Treat; 2014 Dec; 25(6):459-61. PubMed ID: 24192062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience.
    Nettis E; Cegolon L; Di Leo E; Canonica WG; Detoraki A;
    Ann Allergy Asthma Immunol; 2018 Mar; 120(3):318-323. PubMed ID: 29508719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of urticaria with H1 and H2 antihistaminics. Results of clinical and experimental studies].
    Paul E; Pfeffer M; Bödeker RH
    Z Hautkr; 1987 Mar; 62(5):401-2, 405-6. PubMed ID: 2884788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omalizumab therapy for treatment of recalcitrant chronic spontaneous urticaria in an Asian population.
    Kulthanan K; Tuchinda P; Chularojanamontri L; Likitwattananurak C; Ungaksornpairote C
    J Dermatolog Treat; 2017 Mar; 28(2):160-165. PubMed ID: 27388043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.
    Saini S; Rosen KE; Hsieh HJ; Wong DA; Conner E; Kaplan A; Spector S; Maurer M
    J Allergy Clin Immunol; 2011 Sep; 128(3):567-73.e1. PubMed ID: 21762974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic autoimmune urticaria with omalizumab.
    Kaplan AP; Joseph K; Maykut RJ; Geba GP; Zeldin RK
    J Allergy Clin Immunol; 2008 Sep; 122(3):569-73. PubMed ID: 18774392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion.
    Vestergaard C; Toubi E; Maurer M; Triggiani M; Ballmer-Weber B; Marsland A; Ferrer M; Knulst A; Giménez-Arnau A
    Eur J Dermatol; 2017 Feb; 27(1):10-19. PubMed ID: 27882879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of chronic idiopathic urticaria unresponsive to type 1 antihistamines in monotherapy].
    Mateus C
    Ann Dermatol Venereol; 2003 May; 130 Spec No 1():1S129-44. PubMed ID: 12843818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria.
    Nelson HS; Reynolds R; Mason J
    Ann Allergy Asthma Immunol; 2000 May; 84(5):517-22. PubMed ID: 10831005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levocetirizine and rupatadine in chronic idiopathic urticaria.
    Johnson M; Kwatra G; Badyal DK; Thomas EA
    Int J Dermatol; 2015 Oct; 54(10):1199-204. PubMed ID: 25521304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study.
    Ghazanfar MN; Holm JG; Thomsen SF
    J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1761-1767. PubMed ID: 29729103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six cases of antihistamine-resistant dermographic urticaria treated with oral ciclosporin.
    Toda S; Takahagi S; Mihara S; Hide M
    Allergol Int; 2011 Dec; 60(4):547-50. PubMed ID: 21778816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiety, depression, psychosomatic symptoms and autonomic nervous function in patients with chronic urticaria.
    Hashiro M; Okumura M
    J Dermatol Sci; 1994 Oct; 8(2):129-35. PubMed ID: 7841156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emedastine difumarate versus loratadine in chronic idiopathic urticaria: a randomized, double-blind, controlled European multicentre clinical trial.
    Pons-Guiraud A; Nekam K; Lahovsky J; Costa A; Piacentini A
    Eur J Dermatol; 2006; 16(6):649-54. PubMed ID: 17229605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic options in idiopathic chronic urticaria].
    Mora PM; González Pérez Mdel C; Jiménez Villarruel M; Rodriguez Castro E; Fogelbach GG
    Rev Alerg Mex; 2005; 52(2):77-82. PubMed ID: 16158780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bibliographic review of antihistaminics H2 in the treatment of chronic (or recurrent) idiopathic urticaria].
    Gay G; Drouet M; Bonneau JC; Le Sellin J; Sabbah A
    Allerg Immunol (Paris); 1988 Dec; 20(10):377-8. PubMed ID: 2905603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of chronic urticaria of unknown origin with a combination of H1 and H2 antihistaminics].
    Novikov DK; Dotsenko EA; Kolosova TS
    Klin Med (Mosk); 1989 Apr; 67(4):101-3. PubMed ID: 2569048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.